Nerve block vs. painkiller: which works better for obese patients after chest surgery?

NCT ID NCT07391475

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two ways to manage pain after video-assisted chest surgery in 102 obese patients. One group received an ultrasound-guided nerve block (erector spinae plane block) with bupivacaine, while the other group got an intravenous painkiller (nalbuphine). The goal was to see which method provides longer-lasting pain relief and reduces the need for extra pain medication. The trial is complete and results will help guide pain management in this specific patient group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bupivacaine (nerve block) and Nalbuphine (intravenous painkiller)
What this could lead to
If the nerve block works better, it could offer a safer, more effective way to manage pain after chest surgery in obese patients, reducing the need for strong painkillers.
What could go wrong
This is a small, single-center study. The nerve block may not provide better pain relief than the standard drug, and there are risks like infection or bleeding from the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ZagazigU

    Zagazig, Zagazig, 055, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.